Clinical trial Recruiting at 1 site Observational Ages 10 to 14

Neurotrophic factors, impulsivity, and reward in children with internet gaming disorder

Official title: Investigation of the Relationship Between Serum BDNF and GDNF Levels and Impulsivity, Reward/Punishment Sensitivity in Children Diagnosed With Internet Gaming Disorder

Run by Istanbul Saglik Bilimleri University · NCT07590180 · Data updated 2026-11-12

This study tests whether kids aged 10–14 with internet gaming disorder have different levels of brain-derived and glial-derived neurotrophic factors compared with healthy peers.

More Internet Gaming Disorder trials

Quick facts

Study typeObservational
Ages10 Years to 14 Years
SexAll
Enrollment120 (estimated)
SponsorIstanbul Saglik Bilimleri University
Academic / other
Locations1 site (Istanbul, Bakirkoy)
StatusRecruiting
StartedMay 1, 2026
Main results expectedDecember 2026
Study endsJanuary 2027
Registry record updatedMay 15, 2026
Trial IDNCT07590180 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 10–14 diagnosed with IGD by DSM-5 criteria and meeting study eligibility, alongside age- and sex-mimicked healthy controls without neuropsychiatric disorders.

Probably not a fit

Some participants may not show differences in neurotrophic factors or may not benefit directly from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional case-control study compares serum BDNF and GDNF levels between children with Internet Gaming Disorder and age- and gender-matched healthy controls. It also examines how these neurotrophic factors relate to IGD severity and various behavioral and emotional measures using standardized psychometric tools. Participants and their parents will undergo clinical interviews and provide informed consent, with data collected from May to December 2026 at a psychiatric outpatient setting in Istanbul. The analysis will explore associations between biomarkers and behavioral assessments to understand potential neurobiological underpinnings of IGD in youth.

Why it matters

Potential benefit: If successful, the study could help clarify biological markers linked to IGD and guide future biomarker-informed approaches for assessment or intervention in youth.

How similar studies have gone: Other research has begun to link neurotrophic factors to behavioral conditions, but application to pediatric IGD is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For IGD Patient Group:

Age: Being between 10 and 14 years of age. Literacy: Ability to read and write fluently. Informed Consent: Voluntary participation with written informed consent obtained from both the participants and their parents/legal guardians after a comprehensive briefing on the study procedures and scales.

Diagnostic Criteria: Meeting the DSM-5 diagnostic criteria for Internet Gaming Disorder (IGD) and scoring above the clinical cutoff on the Internet Gaming Disorder Scale-Short Form (IGDS9-SF).

For Healthy Control Group:

Age: Children between 10 and 14 years of age. Literacy: Ability to read and write fluently. Clinical Status: No history or current diagnosis of any neuropsychiatric disorder, confirmed through clinical psychiatric assessment.

Informed Consent: Voluntary participation with written informed consent obtained from both the participants and their parents/legal guardians after a comprehensive briefing on the study procedures and scales.

Exclusion Criteria:

Comorbid Psychiatric Disorders: Meeting the DSM-5 diagnostic criteria for Autism Spectrum Disorder, Schizophrenia, Bipolar I Disorder, or Bipolar II Disorder.

Cognitive and Neurological Impairment: Having a moderate to severe intellectual disability and/or a neurological disease in either the child or the caregiver that would impede the ability to understand instructions or provide reliable responses during the interview.

Lack of Informed Consent: Refusal to participate voluntarily or failure to sign the informed consent/assent form by the children or their parents/legal guardians after receiving a detailed explanation of the study's purpose and the assessment scales to be administered.

Where it's running

  • Bakırköy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery
    Istanbul, Bakirkoy, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.